Why Virtual Reality is the Future for Columbia Cancer Research
Simon Tavaré, Director of the Irving Institute for Cancer Dynamics and Professor of Statistics and Biological Sciences, is establishing a Virtual Reality lab to visualize tumors in 3D. Simon is a member of the IMAXT team, an initiative supported by Cancer Grand Challenges (funded by Cancer Research UK and the National Cancer Institute) that connects more than 90 investigators across 5 countries. One goal of the IMAXT VR project is "to allow multiple investigators to immerse themselves simultaneously in the same tumor, providing a novel way to identify molecular features of the tumor," Simon explains. This way, they can study where the cell types are in a tumor sample and develop a more detailed picture of how these cells interact at the molecular level.
Watch the video here (via Columbia YouTube).